Today: Accelerating Medical and Drug Discovery To be sure, the quality of these tools and their promise varies, but given there is already reliance on AI to accelerate disease insights and drug development, we should be accelerating work on guardrails too. Among the bigger governance challenges is assessing the reliability, safety, and fairness of such tools. In many instances, a well-designed audit framework would enable leaders to evaluate whether the system is trustworthy but this can be challenging in practice. Tomorrow: Enabling Population Management and Limiting Disease Spread Tracking COVID-19 patients and their contacts is widely understood to be central to the effort to contain spread and eventually, loosen the restrictions on our mobility and economic activity. The AI/ML-enabled contact tracing tools that were so effective in Singapore and South Korea are now, in some form, likely coming to the EU and US.